Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant
Kathryn A. Ryan, Kevin R. Bewley, Robert J. Watson, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1011293-e1011293
Open Access | Times Cited: 18

Showing 18 citing articles:

Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study
Waasila Jassat, Salim S. Abdool Karim, Caroline Mudara, et al.
The Lancet Global Health (2022) Vol. 10, Iss. 7, pp. e961-e969
Open Access | Times Cited: 184
Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
David J. Sullivan, Massimo Franchini, Michael J. Joyner, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 78
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
Hao Zhou, Michelle Møhlenberg, Jigarji Chaturji Thakor, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 67
Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice
Shufeng Liu, Prabhuanand Selvaraj, Kotou Sangare, et al.
Cell Reports (2022) Vol. 40, Iss. 11, pp. 111359-111359
Open Access | Times Cited: 29
SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum
Alastair Handley, Kathryn A. Ryan, Elizabeth R. Davies, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 748-748
Open Access | Times Cited: 12
Evaluation of the cross reactivity of neutralising antibody response in vaccinated human and convalescent hamster sera against SARS-CoV-2 variants up to and including JN.1 using an authentic virus neutralisation assay
Naomi S. Coombes, Kevin R. Bewley, Yann Le Duff, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Predicting COVID-19 disease severity from SARS-CoV-2 spike protein sequence by mixed effects machine learning
Bahrad A. Sokhansanj, Gail Rosen
Computers in Biology and Medicine (2022) Vol. 149, pp. 105969-105969
Open Access | Times Cited: 14
Analysis of anti-Omicron neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
David J. Sullivan, Massimo Franchini, Michael J. Joyner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 15
Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development
Robert Jordan, Stephanie L. Ford‐Scheimer, Rodolfo Alarcón, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_5, pp. S337-S354
Open Access | Times Cited: 5
Infection with Seasonal H1N1 Influenza Results in Comparable Disease Kinetics and Host Immune Responses in Ferrets and Golden Syrian Hamsters
Jemma Paterson, Kathryn A. Ryan, Daniel Morley, et al.
Pathogens (2023) Vol. 12, Iss. 5, pp. 668-668
Open Access | Times Cited: 3
Omicron breakthrough infections in vaccinated or previously infected hamsters
Jie Zhou, Ksenia Sukhova, Thomas P. Peacock, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 45
Open Access | Times Cited: 3
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2
Maarten Swart, Joan van der Lubbe, Sonja Schmit-Tillemans, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 2
The Omicron Sub-Variant BA.4 Displays a Remarkable Lack of Clinical Signs in a Golden Syrian Hamster Model of SARS-CoV-2 Infection
Elizabeth R. Davies, Kathryn A. Ryan, Kevin R. Bewley, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1133-1133
Open Access | Times Cited: 2
Detection of SARS-CoV-2 BA.2.86 by lateral flow devices
Abbie Bown, Angela Sweed, Matthew Catton, et al.
International Journal of Infectious Diseases (2023) Vol. 139, pp. 168-170
Open Access | Times Cited: 2
Global variation in prior exposure shapes antibody neutralization profiles of SARS-CoV-2 variants up to BA.2.86
S. Richard Turner, Gayatri Amirthalingam, Dalan Bailey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Combined mutations in nonstructural protein 14, envelope, and membrane proteins mitigate the neuropathogenicity of SARS-CoV-2 Omicron BA.1 in K18-hACE2 mice
Kotou Sangare, Shufeng Liu, Prabhuanand Selvaraj, et al.
mSphere (2024)
Open Access
Modelling SARS-CoV-2 infection in a human alveolus microphysiological system
Tanja Šuligoj, Naomi S. Coombes, Catherine Booth, et al.
Access Microbiology (2024) Vol. 6, Iss. 9
Open Access
Preclinical and Human Phase 1 Studies of Aerosolized Hydroxychloroquine: Implications for Antiviral COVID-19 Therapy
Ohad S. Bentur, Richard Hutt, Donna Brassil, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top